Semler Scientific (SMLR) Competitors

Cadre (NYSE:CDRE) and Semler Scientific (NASDAQ:SMLR) are both small-cap industrials companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, dividends, risk, profitability, community ranking, institutional ownership and media sentiment.

Which has preferable valuation and earnings, CDRE or SMLR?

Cadre has higher revenue and earnings than Semler Scientific. Semler Scientific is trading at a lower price-to-earnings ratio than Cadre, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cadre	$567.56M	2.20	$38.64M	$0.90	34.20
Semler Scientific	$56.29M	5.73	$20.58M	$4.91	6.85

Does the MarketBeat Community prefer CDRE or SMLR?

Cadre received 14 more outperform votes than Semler Scientific when rated by MarketBeat users. However, 66.67% of users gave Semler Scientific an outperform vote while only 55.17% of users gave Cadre an outperform vote.

Company	Underperform	Outperform
Cadre	Outperform Votes 16 55.17%	Underperform Votes 13 44.83%
Semler Scientific	Outperform Votes 2 66.67%	Underperform Votes 1 33.33%

Do insiders & institutionals have more ownership in CDRE or SMLR?

44.0% of Cadre shares are held by institutional investors. Comparatively, 49.4% of Semler Scientific shares are held by institutional investors. 37.0% of Cadre shares are held by company insiders. Comparatively, 30.2% of Semler Scientific shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Do analysts recommend CDRE or SMLR?

Cadre presently has a consensus target price of $37.00, suggesting a potential upside of 20.21%. Semler Scientific has a consensus target price of $71.00, suggesting a potential upside of 111.25%. Given Semler Scientific's higher probable upside, analysts clearly believe Semler Scientific is more favorable than Cadre.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cadre	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Semler Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has more risk and volatility, CDRE or SMLR?

Cadre has a beta of 1.33, suggesting that its stock price is 33% more volatile than the S&P 500. Comparatively, Semler Scientific has a beta of 1.29, suggesting that its stock price is 29% more volatile than the S&P 500.

Does the media refer more to CDRE or SMLR?

In the previous week, Cadre had 2 more articles in the media than Semler Scientific. MarketBeat recorded 6 mentions for Cadre and 4 mentions for Semler Scientific. Semler Scientific's average media sentiment score of 1.49 beat Cadre's score of 0.54 indicating that Semler Scientific is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cadre	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Semler Scientific	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is CDRE or SMLR more profitable?

Semler Scientific has a net margin of 72.65% compared to Cadre's net margin of 6.34%. Semler Scientific's return on equity of 50.77% beat Cadre's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cadre	6.34%	12.88%	6.06%
Semler Scientific	72.65%	50.77%	47.04%

Summary

Semler Scientific beats Cadre on 9 of the 16 factors compared between the two stocks.